No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4iuaA, 1.0000, 0.00, 1.000, 254, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
2, 4iuaD, 0.9813, 0.49, 1.000, 254, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
3, 4iuaE, 0.9681, 0.66, 1.000, 254, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
4, 4iuaB, 0.9671, 0.73, 1.000, 254, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
5, 4iuaC, 0.9615, 0.74, 1.000, 254, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
6, 4iuaF, 0.9576, 0.77, 1.000, 254, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
7, 3hmrA, 0.9389, 1.05, 1.000, 90, 90, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (31-127) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
8, 2qj4B, 0.9277, 0.99, 0.989, 172, 89, A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST
9, 2qj4A, 0.9277, 0.99, 0.989, 172, 89, A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST
10, 2qj2B, 0.9276, 1.27, 0.824, 175, 91, A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST
11, 3hmsA, 0.9192, 1.52, 0.835, 91, 91, CRYSTAL CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (28-126) OF THE HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR ORTHORHOMBIC CRYSTAL FORM
12, 3hmtA, 0.9160, 1.31, 0.835, 91, 91, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (28-126) OF THE HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR TRIGONAL CRYSTAL FORM
13, 3hmtB, 0.9156, 1.30, 0.835, 91, 91, CRYSTAL STRUCTURE OF THE N-TERMINAL FRAGMENT (28-126) OF THE HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR TRIGONAL CRYSTAL FORM
14, 1gmnA, 0.9142, 1.35, 0.809, 170, 89, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
15, 1bhtB, 0.9141, 1.45, 0.824, 174, 91, NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR
16, 3mkpB, 0.9140, 1.36, 0.824, 173, 91, CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN
17, 3mkpA, 0.9139, 1.32, 0.824, 173, 91, CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN
18, 1bhtA, 0.9128, 1.36, 0.824, 176, 91, NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR
19, 5cs9B, 0.9122, 1.35, 0.824, 174, 91, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MES
20, 5cs1B, 0.9118, 1.36, 0.824, 174, 91, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF
21, 2qj2A, 0.9118, 1.42, 0.824, 174, 91, A MECHANISTIC BASIS FOR CONVERTING A RECEPTOR TYROSINE KINASE AGONIST TO AN ANTAGONIST
22, 3hn4A, 0.9094, 1.50, 0.835, 256, 91, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (28-289) OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
23, 1gmoF, 0.9090, 1.36, 0.811, 173, 90, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
24, 1gmoB, 0.9086, 1.38, 0.811, 172, 90, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
25, 5cp9B, 0.9083, 1.33, 0.822, 173, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MB605
26, 1gmoC, 0.9074, 1.33, 0.811, 172, 90, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
27, 5ct1B, 0.9069, 1.32, 0.822, 173, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH CHES
28, 5ct3B, 0.9056, 1.33, 0.822, 173, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH 2FA
29, 5csqB, 0.9055, 1.36, 0.822, 173, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MOPS
30, 5cs3B, 0.9053, 1.37, 0.822, 173, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH (H)EPPS
31, 3mkpC, 0.9052, 1.48, 0.824, 173, 91, CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN
32, 5coeB, 0.9051, 1.34, 0.822, 173, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH HEPES
33, 5cs5B, 0.9049, 1.36, 0.822, 173, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH PIPES
34, 1gmoA, 0.9045, 1.39, 0.811, 172, 90, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
35, 3sp8B, 0.9039, 1.33, 0.822, 256, 90, CRYSTAL STRUCTURE OF NK2 IN COMPLEX WITH FRACTIONATED HEPARIN DP10
36, 5ct3A, 0.9021, 1.33, 0.820, 173, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH 2FA
37, 5ct1A, 0.9018, 1.35, 0.820, 173, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH CHES
38, 5cp9A, 0.9012, 1.36, 0.820, 173, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MB605
39, 5cs1A, 0.9011, 1.35, 0.820, 172, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF
40, 5cs5A, 0.9009, 1.35, 0.820, 173, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH PIPES
41, 1gmoD, 0.9007, 1.44, 0.811, 172, 90, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
42, 1gmoE, 0.9003, 1.41, 0.811, 173, 90, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
43, 5ct2A, 0.9002, 1.37, 0.820, 173, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH CAPS
44, 5cs3A, 0.9002, 1.33, 0.820, 173, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH (H)EPPS
45, 1gp9C, 0.9001, 1.37, 0.820, 171, 89, A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING
46, 5csqA, 0.9000, 1.37, 0.820, 173, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MOPS
47, 5coeA, 0.9000, 1.36, 0.820, 173, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH HEPES
48, 3sp8A, 0.8984, 1.40, 0.822, 255, 90, CRYSTAL STRUCTURE OF NK2 IN COMPLEX WITH FRACTIONATED HEPARIN DP10
49, 5cs9A, 0.8972, 1.39, 0.820, 172, 89, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH MES
50, 5ct2B, 0.8970, 1.38, 0.822, 173, 90, THE STRUCTURE OF THE NK1 FRAGMENT OF HGF/SF COMPLEXED WITH CAPS
51, 1nk1A, 0.8970, 1.41, 0.820, 172, 89, NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION
52, 4iuaH, 0.8965, 0.46, 1.000, 246, 83, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
53, 1nk1B, 0.8947, 1.42, 0.820, 172, 89, NK1 FRAGMENT OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) AT 2.5 ANGSTROM RESOLUTION
54, 1gmoH, 0.8944, 1.42, 0.809, 171, 89, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
55, 1gp9A, 0.8917, 1.38, 0.818, 170, 88, A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING
56, 1gp9D, 0.8866, 1.40, 0.818, 170, 88, A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING
57, 1gp9B, 0.8861, 1.36, 0.818, 170, 88, A NEW CRYSTAL FORM OF THE NK1 SPLICE VARIANT OF HGF/SF DEMONSTRATES EXTENSIVE HINGE MOVEMENT AND SUGGESTS THAT THE NK1 DIMER ORIGINATES BY DOMAIN SWAPPING
58, 4iuaG, 0.8858, 0.69, 1.000, 246, 83, CRYSTAL STRUCTURE OF THE NK2 FRAGMENT (31-290) OF THE MOUSE HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR
59, 3mkpD, 0.8752, 1.37, 0.828, 169, 87, CRYSTAL STRUCTURE OF 1K1 MUTANT OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR FRAGMENT NK1 IN COMPLEX WITH HEPARIN
60, 1gmoG, 0.8521, 0.92, 0.829, 164, 82, CRYSTAL STRUCTURES OF NK1-HEPARIN COMPLEXES REVEAL THE BASIS FOR NK1 ACTIVITY AND ENABLE ENGINEERING OF POTENT AGONISTS OF THE MET RECEPTOR
61, 2hgfA, 0.8195, 1.95, 0.843, 97, 89, HAIRPIN LOOP CONTAINING DOMAIN OF HEPATOCYTE GROWTH FACTOR NMR MINIMIZED AVERAGE STRUCTURE
62, 4durB, 0.8116, 1.29, 0.247, 754, 81, THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE II HUMAN PLASMINOGEN
63, 4durA, 0.8000, 1.29, 0.250, 756, 80, THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE II HUMAN PLASMINOGEN
64, 4a5tS, 0.7976, 1.57, 0.244, 767, 82, STRUCTURAL BASIS FOR THE CONFORMATIONAL MODULATION
65, 4duuA, 0.7848, 1.34, 0.250, 682, 80, THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE I HUMAN PLASMINOGEN
66, 5h7vA, 0.7123, 2.43, 0.157, 320, 83, STRUCTURE OF FULL-LENGTH EXTRACELLULAR DOMAIN OF HAI-1 AT PH 4.6
67, 2msxA, 0.6983, 2.86, 0.155, 114, 84, THE SOLUTION STRUCTURE OF THE MANEC-TYPE DOMAIN FROM HEPATOCYTE GROWTH FACTOR INHIBITOR 1 REVEALS AN UNEXPECTED PAN/APPLE DOMAIN-TYPE FOLD
68, 4apmA, 0.6663, 3.06, 0.075, 339, 80, CRYSTAL STRUCTURE OF AMA1 FROM BABESIA DIVERGENS
69, 4yivA, 0.6643, 3.20, 0.095, 374, 84, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP
70, 2y8sA, 0.6628, 3.08, 0.096, 386, 83, CO-STRUCTURE OF AN AMA1 MUTANT (Y230A) WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
71, 4aplD, 0.6626, 3.08, 0.108, 395, 83, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
72, 2y8tA, 0.6613, 3.10, 0.096, 388, 83, CO-STRUCTURE OF AMA1 WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
73, 4aplE, 0.6606, 3.03, 0.108, 390, 83, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
74, 4aplB, 0.6598, 3.04, 0.108, 394, 83, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
75, 2x2zA, 0.6596, 3.12, 0.096, 407, 83, CRYSTAL STRUCTURE AMA1 FROM TOXOPLASMA GONDII
76, 4yizC, 0.6593, 3.10, 0.096, 392, 83, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE
77, 4yizA, 0.6593, 3.09, 0.096, 392, 83, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE
78, 2x2zE, 0.6593, 3.02, 0.096, 396, 83, CRYSTAL STRUCTURE AMA1 FROM TOXOPLASMA GONDII
79, 2y8sD, 0.6590, 3.13, 0.096, 391, 83, CO-STRUCTURE OF AN AMA1 MUTANT (Y230A) WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
80, 2y8tD, 0.6586, 3.11, 0.096, 395, 83, CO-STRUCTURE OF AMA1 WITH A SURFACE EXPOSED REGION OF RON2 FROM TOXOPLASMA GONDII
81, 2z8vB, 0.6584, 3.00, 0.050, 335, 80, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
82, 2yioB, 0.6583, 2.42, 0.145, 131, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP C2221).
83, 2yilA, 0.6581, 2.31, 0.145, 131, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
84, 2x2zD, 0.6580, 3.10, 0.096, 367, 83, CRYSTAL STRUCTURE AMA1 FROM TOXOPLASMA GONDII
85, 1i8nC, 0.6580, 2.78, 0.139, 89, 79, CRYSTAL STRUCTURE OF LEECH ANTI-PLATELET PROTEIN
86, 4yizE, 0.6579, 3.10, 0.096, 388, 83, CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE
87, 2yipB, 0.6579, 2.36, 0.145, 131, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
88, 2yilE, 0.6578, 2.38, 0.145, 130, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
89, 2z8vA, 0.6573, 2.99, 0.050, 335, 80, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
90, 2z8wB, 0.6571, 3.00, 0.050, 335, 80, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
91, 2yipC, 0.6569, 2.32, 0.145, 131, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
92, 2x2zB, 0.6569, 3.10, 0.096, 401, 83, CRYSTAL STRUCTURE AMA1 FROM TOXOPLASMA GONDII
93, 2z8wA, 0.6568, 2.98, 0.050, 335, 80, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
94, 2y8rA, 0.6568, 3.14, 0.096, 399, 83, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
95, 2yipE, 0.6563, 2.39, 0.145, 131, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
96, 2yilC, 0.6563, 2.39, 0.145, 131, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
97, 2yipA, 0.6559, 2.37, 0.145, 131, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
98, 2yipF, 0.6556, 2.39, 0.145, 131, 76, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
99, 2y8rE, 0.6551, 3.11, 0.096, 394, 83, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
100, 2q8aA, 0.6545, 2.96, 0.050, 316, 80, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
101, 4r19B, 0.6538, 2.97, 0.075, 317, 80, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
102, 2y8rD, 0.6536, 3.12, 0.096, 406, 83, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
103, 2y8rB, 0.6535, 3.08, 0.096, 397, 83, CRYSTAL STRUCTURE OF APO AMA1 MUTANT (TYR230ALA) FROM TOXOPLASMA GONDII
104, 2q8bA, 0.6535, 2.99, 0.050, 292, 80, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
105, 4r19A, 0.6515, 3.02, 0.050, 321, 80, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
106, 1i8nA, 0.6512, 2.83, 0.139, 89, 79, CRYSTAL STRUCTURE OF LEECH ANTI-PLATELET PROTEIN
107, 5nqgA, 0.6510, 3.02, 0.125, 382, 80, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX AMA1 IN COMPLEX WITH A 39 AA PVRON2 PEPTIDE
108, 2yilF, 0.6510, 2.42, 0.147, 129, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
109, 4r1bA, 0.6506, 3.02, 0.050, 282, 80, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
110, 1z40A, 0.6505, 3.01, 0.050, 311, 80, AMA1 FROM PLASMODIUM FALCIPARUM
111, 1i8nB, 0.6504, 2.84, 0.139, 89, 79, CRYSTAL STRUCTURE OF LEECH ANTI-PLATELET PROTEIN
112, 1w81A, 0.6501, 3.05, 0.137, 364, 80, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM VIVAX
113, 1w8kA, 0.6491, 3.02, 0.125, 362, 80, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM VIVAX
114, 3zwzA, 0.6484, 3.07, 0.075, 297, 80, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 39AA PFRON2 PEPTIDE
115, 3sriA, 0.6479, 3.05, 0.087, 286, 80, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 29AA PFRON2 PEPTIDE
116, 4z09A, 0.6475, 3.05, 0.087, 270, 80, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [THR2040ALA] PEPTIDE
117, 4z0dA, 0.6474, 3.04, 0.087, 273, 80, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038TRP] PEPTIDE
118, 4r1aA, 0.6474, 3.05, 0.087, 265, 80, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1
119, 2yipD, 0.6473, 2.39, 0.147, 130, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP P212121)
120, 2yilB, 0.6473, 2.39, 0.147, 129, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
121, 3srjB, 0.6471, 3.06, 0.075, 297, 80, PFAMA1 IN COMPLEX WITH INVASION-INHIBITORY PEPTIDE R1
122, 2yilD, 0.6471, 2.41, 0.147, 129, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS LECTIN SML-2
123, 4z80B, 0.6469, 3.27, 0.072, 466, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII AMA4 DI-DII-EGF1 IN COMPLEX WITH A 33 AA TGRON2L1 PEPTIDE
124, 4uv6A, 0.6468, 3.10, 0.125, 336, 80, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI
125, 4z0eA, 0.6467, 3.05, 0.087, 270, 80, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038TRN] PEPTIDE
126, 3srjA, 0.6465, 3.06, 0.075, 298, 80, PFAMA1 IN COMPLEX WITH INVASION-INHIBITORY PEPTIDE R1
127, 4z0fA, 0.6463, 3.05, 0.087, 278, 80, CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038(6CW)] PEPTIDE
128, 2yioA, 0.6462, 2.43, 0.147, 128, 75, CRYSTAL STRUCTURE OF PARASITE SARCOCYSTIS MURIS MICRONEME PROTEIN SML-2  IN COMPLEX WITH 1-THIO-BETA-D-GALACTOSE ( SPACEGROUP C2221).
129, 4uv6B, 0.6461, 3.10, 0.125, 336, 80, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI
130, 5nqfA, 0.6453, 3.07, 0.087, 298, 80, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 39 AA PVRON2 PEPTIDE
131, 5eokA, 0.6451, 2.72, 0.133, 589, 75, HUMAN PLASMA COAGULATION FACTOR XI IN COMPLEX WITH PEPTIDE P39
132, 5i25A, 0.6444, 2.98, 0.132, 596, 76, HUMAN RECOMBINANT COAGULATION FXI IN COMPLEX WITH A PEPTIDE DERIVED FROM HUMAN HIGH MOLECULAR WEIGHT KININOGEN (HKP)
133, 4a5vA, 0.6444, 2.83, 0.077, 161, 78, SOLUTION STRUCTURE ENSEMBLE OF THE TWO N-TERMINAL APPLE DOMAINS (RESIDUES 58-231) OF TOXOPLASMA GONDII MICRONEME PROTEIN 4
134, 4uaoA, 0.6432, 3.23, 0.123, 332, 81, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY
135, 2f83A, 0.6432, 3.03, 0.132, 583, 76, CRYSTAL STRUCTURE AT 2.9 ANGSTROMS RESOLUTION OF HUMAN PLASMA COAGULATION FACTOR XI ZYMOGEN
136, 3zleE, 0.6376, 3.28, 0.107, 382, 84, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
137, 3zleL, 0.6374, 3.25, 0.107, 380, 84, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
138, 3zleK, 0.6359, 3.27, 0.107, 380, 84, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
139, 3zleH, 0.6358, 3.26, 0.107, 380, 84, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
140, 4z80A, 0.6338, 3.40, 0.102, 466, 88, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII AMA4 DI-DII-EGF1 IN COMPLEX WITH A 33 AA TGRON2L1 PEPTIDE
141, 3zleB, 0.6330, 3.12, 0.108, 379, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
142, 3zleI, 0.6327, 3.25, 0.107, 375, 84, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
143, 3zleF, 0.6325, 3.08, 0.108, 377, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
144, 4z81B, 0.6324, 3.54, 0.091, 496, 88, CRYSTAL STRUCTURE OF AMA4 DI-DII-EGF1 FROM TOXOPLASMA GONDII
145, 4z81A, 0.6323, 3.53, 0.091, 500, 88, CRYSTAL STRUCTURE OF AMA4 DI-DII-EGF1 FROM TOXOPLASMA GONDII
146, 3zleA, 0.6314, 3.11, 0.108, 382, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
147, 3zleJ, 0.6308, 3.12, 0.108, 379, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
148, 3zldA, 0.6305, 3.26, 0.108, 363, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1 IN COMPLEX WITH A 36 AA REGION OF SPOROZOITE RON2
149, 3zleG, 0.6304, 3.12, 0.108, 382, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
150, 3zleC, 0.6302, 3.10, 0.108, 379, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
151, 3zleD, 0.6301, 3.09, 0.108, 380, 83, CRYSTAL STRUCTURE OF TOXOPLASMA GONDII SPOROZOITE AMA1
152, 4r1cA, 0.6260, 3.35, 0.059, 279, 85, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
153, 4r1cB, 0.6236, 3.18, 0.060, 262, 83, CRYSTAL STRUCTURE OF 3D7 STRAIN PLASMODIUM FALCIPARUM AMA1
154, 1z40E, 0.6234, 3.39, 0.059, 306, 85, AMA1 FROM PLASMODIUM FALCIPARUM
155, 4aplA, 0.6232, 3.38, 0.131, 398, 84, CRYSTAL STRUCTURE OF AMA1 FROM NEOSPORA CANINUM
156, 2ll4M, 0.6171, 2.21, 0.132, 70, 68, HADDOCK STRUCTURE OF TGMIC4-A5/LACTO-N-BIOSE COMPLEX BASED ON NOE- DERIVED DISTANCE RESTRAINTS
157, 5eodA, 0.6170, 3.26, 0.143, 586, 77, HUMAN PLASMA COAGULATION FXI WITH PEPTIDE LP2
158, 5gyyB, 0.6139, 3.05, 0.160, 405, 75, PLANT RECEPTOR COMPLEX
159, 2ll3A, 0.6117, 2.23, 0.147, 70, 68, THE SOLUTION STRUCTURE OF TGMIC4 APPLE-5 DOMAIN
160, 5gyyA, 0.6057, 3.16, 0.171, 400, 76, PLANT RECEPTOR COMPLEX
161, 2j8jA, 0.5890, 2.94, 0.133, 90, 75, SOLUTION STRUCTURE OF THE A4 DOMAIN OF BLOOD COAGULATION FACTOR XI
162, 2j8lA, 0.5835, 3.10, 0.145, 90, 76, FXI APPLE 4 DOMAIN LOOP-OUT CONFORMATION
163, 4d3cA, 0.5776, 0.80, 0.836, 137, 55, CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68.
164, 2j8lB, 0.5760, 3.16, 0.145, 90, 76, FXI APPLE 4 DOMAIN LOOP-OUT CONFORMATION
165, 2k13X, 0.5691, 3.25, 0.154, 103, 78, SOLUTION NMR STRUCTURE OF THE LEECH PROTEIN SARATIN A NOVEL INHIBITOR OF HAEMOSTASIS
166, 2j8jB, 0.5680, 3.31, 0.143, 90, 77, SOLUTION STRUCTURE OF THE A4 DOMAIN OF BLOOD COAGULATION FACTOR XI
167, 1hkyA, 0.5533, 3.06, 0.149, 86, 74, SOLUTION STRUCTURE OF A PAN MODULE FROM EIMERIA TENELLA
168, 5fwwB, 0.5441, 3.56, 0.125, 288, 72, WNT MODULATOR KREMEN IN COMPLEX WITH DKK1 (CRD2) AND LRP6 (PE3PE4)
169, 5fwtA, 0.5392, 3.62, 0.141, 293, 71, WNT MODULATOR KREMEN CRYSTAL FORM I AT 2.10A
170, 5fwsA, 0.5384, 3.44, 0.129, 288, 70, WNT MODULATOR KREMEN CRYSTAL FORM I AT 1.90A
171, 5fwvA, 0.5373, 3.60, 0.127, 294, 71, WNT MODULATOR KREMEN CRYSTAL FORM III AT 3.2A
172, 5fwuA, 0.5371, 3.75, 0.137, 271, 73, WNT MODULATOR KREMEN CRYSTAL FORM II AT 2.8A
